ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1499

$1.6M Total Retail Price of All Prescriptions

Rank: 18 out of 1499

612 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,016 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
POLYETHYLENE GLYCOL 3350 740 133 1 52
LEVOTHYROXINE SODIUM 719 204 2 2
OMEPRAZOLE 625 287 3 5
FUROSEMIDE 556 360 4 7
TRAZODONE HCL 462 167 5 32
CITALOPRAM HBR 457 176 6 14
LISINOPRIL 397 249 7 1
SIMVASTATIN 386 267 8 3
GABAPENTIN 375 187 9 13
POTASSIUM CHLORIDE 352 236 10 11
LAMOTRIGINE 339 0 11 159
QUETIAPINE FUMARATE 338 131 12 72
AMLODIPINE BESYLATE 313 248 13 6
TOPIRAMATE 299 36 14 128
ALENDRONATE SODIUM 295 61 15 33
HYDROCODONE-ACETAMINOPHEN 292 176 S3 16 4
OLANZAPINE 270 20 17 140
WARFARIN SODIUM 250 184 18 12
METOCLOPRAMIDE HCL 249 53 19 114
LACTULOSE 236 0 20 181
DIVALPROEX SODIUM 226 18 21 100
CEPHALEXIN 223 120 22 83
CLONIDINE HCL 222 136 23 57
LEVETIRACETAM 205 36 24 142
RANITIDINE HCL 197 58 25 15
METFORMIN HCL 191 111 26 8
TAMSULOSIN HCL 178 126 27 29
FLUTICASONE PROPIONATE 172 49 28 31
ATORVASTATIN CALCIUM 168 62 29 17
DIVALPROEX SODIUM ER 163 12 30 153
DONEPEZIL HCL 158 157 31 35
SEROQUEL 158 46 31 158
PREDNISONE 156 127 33 42
SERTRALINE HCL 146 57 34 24
VENLAFAXINE HCL ER 141 14 35 96
LEVOFLOXACIN 141 77 35 101
MUPIROCIN 139 28 37 177
METOPROLOL SUCCINATE 139 98 37 20
OXYBUTYNIN CHLORIDE 139 72 37 95
KLOR-CON M20 138 85 40 97
MIRTAZAPINE 137 86 41 50
HYDROCHLOROTHIAZIDE 135 80 42 9
GLIMEPIRIDE 134 71 43 38
METOPROLOL TARTRATE 133 99 44 10
CYMBALTA 130 43 45 40
ABILIFY 127 0 46 143
FAMOTIDINE 126 21 47 86
BENZTROPINE MESYLATE 125 0 R 48 144
FLUOXETINE HCL 122 25 49 43
PAROXETINE HCL 122 37 49 59
ROPINIROLE HCL 118 110 51 55
CELEBREX 117 45 52 77
LIPITOR 117 24 52 107
ALLOPURINOL 116 89 54 36
NAMENDA 116 104 54 47
LANTUS 114 71 56 46
NOVOLOG 114 84 56 110
CLOZAPINE 111 0 58 223
PROPRANOLOL HCL 109 43 59 115
IBUPROFEN 106 22 60 70
IPRATROPIUM-ALBUTEROL 106 56 60 161
CARVEDILOL 104 92 62 22
ZOLPIDEM TARTRATE 103 62 63 23
ZYPREXA 103 0 63 294
LOSARTAN POTASSIUM 102 73 65 26
NEXIUM 102 34 65 28
CARBIDOPA-LEVODOPA 102 85 65 92
SINGULAIR 101 0 68 67
DICLOFENAC SODIUM 99 29 69 131
TRIAMCINOLONE ACETONIDE 99 36 69 126
DICYCLOMINE HCL 97 59 71 181
SEROQUEL XR 97 0 71 196
LOVASTATIN 91 24 73 19
OXYBUTYNIN CHLORIDE ER 91 36 73 141
NITROFURANTOIN 89 25 75 272
FENTANYL 88 80 S2 76 60
TRAMADOL HCL 87 68 77 16
ADVAIR DISKUS 86 43 78 37
OXYCODONE-ACETAMINOPHEN 85 64 S2 79 80
ATENOLOL 85 73 79 21
CRESTOR 83 25 81 34
ISOSORBIDE MONONITRATE ER 81 72 82 51
HYDROXYZINE HCL 80 18 R 83 173
PANTOPRAZOLE SODIUM 80 64 83 48
MEDROXYPROGESTERONE ACETATE 75 0 85 249
METOLAZONE 75 54 85 174
ALBUTEROL SULFATE 75 14 85 152
ESCITALOPRAM OXALATE 74 34 88 76
MELOXICAM 73 54 89 27
DESMOPRESSIN ACETATE 72 0 90 365
CIPROFLOXACIN HCL 72 44 90 65
CLOPIDOGREL 71 45 92 39
ZONISAMIDE 67 0 93 359
DIGOXIN 67 67 93 56
AMITRIPTYLINE HCL 67 37 R 93 49
BENAZEPRIL HCL 66 54 96 93
PRIMIDONE 66 12 96 218
RISPERIDONE 65 0 98 74
MONTELUKAST SODIUM 65 0 98 133
PROAIR HFA 65 50 98 30
HALOPERIDOL 65 18 98 172
SPIRIVA 63 38 102 44
OXCARBAZEPINE 63 0 102 298
IMIPRAMINE HCL 60 0 R 104 304
TRIHEXYPHENIDYL HCL 59 0 R 105 285
PHENYTOIN SODIUM EXTENDED 59 40 105 137
VIMPAT 58 0 107 445
METHYLPREDNISOLONE 56 32 108 135
TORSEMIDE 56 16 108 149
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 39 110 87
VALPROIC ACID 55 0 110 262
MICARDIS HCT 55 55 110 337
NAPROXEN 53 19 113 63
CARBAMAZEPINE 53 12 113 184
EXELON 52 52 115 166
PLAVIX 52 32 115 54
ZOSTAVAX 51 48 117 116
AZITHROMYCIN 50 27 118 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.